Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mitogen-activated protein kinase 1 [8-360] (Homo sapiens (Human)) | BDBM236879 (US9388171, I-8) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.748 | n/a | n/a | n/a | n/a | 7.3 | n/a |
GENETECH, INC.; ARRAY BIOPHARMA INC. US Patent | Assay Description Compounds were tested in an enzymatic assay using human ERK-2 (Mitogen Activated Kinase 1), recombinantly expressed as an n-terminal 6-His fusion pro... | US Patent US9388171 (2016) BindingDB Entry DOI: 10.7270/Q2ZC81SV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mitogen-activated protein kinase 1 [8-360] (Homo sapiens (Human)) | BDBM236882 (US9388171, I-24) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.15 | n/a | n/a | n/a | n/a | 7.3 | n/a |
GENETECH, INC.; ARRAY BIOPHARMA INC. US Patent | Assay Description Compounds were tested in an enzymatic assay using human ERK-2 (Mitogen Activated Kinase 1), recombinantly expressed as an n-terminal 6-His fusion pro... | US Patent US9388171 (2016) BindingDB Entry DOI: 10.7270/Q2ZC81SV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mitogen-activated protein kinase 1 [8-360] (Homo sapiens (Human)) | BDBM236881 (US9388171, I-21) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.86 | n/a | n/a | n/a | n/a | 7.3 | n/a |
GENETECH, INC.; ARRAY BIOPHARMA INC. US Patent | Assay Description Compounds were tested in an enzymatic assay using human ERK-2 (Mitogen Activated Kinase 1), recombinantly expressed as an n-terminal 6-His fusion pro... | US Patent US9388171 (2016) BindingDB Entry DOI: 10.7270/Q2ZC81SV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mitogen-activated protein kinase 1 [8-360] (Homo sapiens (Human)) | BDBM236878 (US9388171, I-6) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.10 | n/a | n/a | n/a | n/a | 7.3 | n/a |
GENETECH, INC.; ARRAY BIOPHARMA INC. US Patent | Assay Description Compounds were tested in an enzymatic assay using human ERK-2 (Mitogen Activated Kinase 1), recombinantly expressed as an n-terminal 6-His fusion pro... | US Patent US9388171 (2016) BindingDB Entry DOI: 10.7270/Q2ZC81SV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mitogen-activated protein kinase 1 [8-360] (Homo sapiens (Human)) | BDBM236886 (US9388171, II-15) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.29 | n/a | n/a | n/a | n/a | 7.3 | n/a |
GENETECH, INC.; ARRAY BIOPHARMA INC. US Patent | Assay Description Compounds were tested in an enzymatic assay using human ERK-2 (Mitogen Activated Kinase 1), recombinantly expressed as an n-terminal 6-His fusion pro... | US Patent US9388171 (2016) BindingDB Entry DOI: 10.7270/Q2ZC81SV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mitogen-activated protein kinase 1 [8-360] (Homo sapiens (Human)) | BDBM236884 (US9388171, II-2) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.5 | n/a | n/a | n/a | n/a | 7.3 | n/a |
GENETECH, INC.; ARRAY BIOPHARMA INC. US Patent | Assay Description Compounds were tested in an enzymatic assay using human ERK-2 (Mitogen Activated Kinase 1), recombinantly expressed as an n-terminal 6-His fusion pro... | US Patent US9388171 (2016) BindingDB Entry DOI: 10.7270/Q2ZC81SV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mitogen-activated protein kinase 1 [8-360] (Homo sapiens (Human)) | BDBM236890 (US9388171, II-64) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.68 | n/a | n/a | n/a | n/a | 7.3 | n/a |
GENETECH, INC.; ARRAY BIOPHARMA INC. US Patent | Assay Description Compounds were tested in an enzymatic assay using human ERK-2 (Mitogen Activated Kinase 1), recombinantly expressed as an n-terminal 6-His fusion pro... | US Patent US9388171 (2016) BindingDB Entry DOI: 10.7270/Q2ZC81SV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mitogen-activated protein kinase 1 [8-360] (Homo sapiens (Human)) | BDBM236885 (US9388171, II-12) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.80 | n/a | n/a | n/a | n/a | 7.3 | n/a |
GENETECH, INC.; ARRAY BIOPHARMA INC. US Patent | Assay Description Compounds were tested in an enzymatic assay using human ERK-2 (Mitogen Activated Kinase 1), recombinantly expressed as an n-terminal 6-His fusion pro... | US Patent US9388171 (2016) BindingDB Entry DOI: 10.7270/Q2ZC81SV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mitogen-activated protein kinase 1 [8-360] (Homo sapiens (Human)) | BDBM236880 (US9388171, I-11) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.43 | n/a | n/a | n/a | n/a | 7.3 | n/a |
GENETECH, INC.; ARRAY BIOPHARMA INC. US Patent | Assay Description Compounds were tested in an enzymatic assay using human ERK-2 (Mitogen Activated Kinase 1), recombinantly expressed as an n-terminal 6-His fusion pro... | US Patent US9388171 (2016) BindingDB Entry DOI: 10.7270/Q2ZC81SV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mitogen-activated protein kinase 1 [8-360] (Homo sapiens (Human)) | BDBM236877 (US9388171, I-5) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.04 | n/a | n/a | n/a | n/a | 7.3 | n/a |
GENETECH, INC.; ARRAY BIOPHARMA INC. US Patent | Assay Description Compounds were tested in an enzymatic assay using human ERK-2 (Mitogen Activated Kinase 1), recombinantly expressed as an n-terminal 6-His fusion pro... | US Patent US9388171 (2016) BindingDB Entry DOI: 10.7270/Q2ZC81SV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mitogen-activated protein kinase 1 [8-360] (Homo sapiens (Human)) | BDBM236888 (US9388171, II-37) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.60 | n/a | n/a | n/a | n/a | 7.3 | n/a |
GENETECH, INC.; ARRAY BIOPHARMA INC. US Patent | Assay Description Compounds were tested in an enzymatic assay using human ERK-2 (Mitogen Activated Kinase 1), recombinantly expressed as an n-terminal 6-His fusion pro... | US Patent US9388171 (2016) BindingDB Entry DOI: 10.7270/Q2ZC81SV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ribosomal protein S6 kinase alpha-1 (Homo sapiens (Human)) | BDBM236890 (US9388171, II-64) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.47 | n/a | n/a | n/a | n/a | n/a | 37 |
GENETECH, INC.; ARRAY BIOPHARMA INC. US Patent | Assay Description HepG2 cells were obtained from ATCC and grown in DMEM supplemented with 10% fetal bovine serum. Cells were plated in 96-well plates at 35,000 cells/w... | US Patent US9388171 (2016) BindingDB Entry DOI: 10.7270/Q2ZC81SV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mitogen-activated protein kinase 1 [8-360] (Homo sapiens (Human)) | BDBM236883 (US9388171, I-30) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.95 | n/a | n/a | n/a | n/a | 7.3 | n/a |
GENETECH, INC.; ARRAY BIOPHARMA INC. US Patent | Assay Description Compounds were tested in an enzymatic assay using human ERK-2 (Mitogen Activated Kinase 1), recombinantly expressed as an n-terminal 6-His fusion pro... | US Patent US9388171 (2016) BindingDB Entry DOI: 10.7270/Q2ZC81SV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ribosomal protein S6 kinase alpha-1 (Homo sapiens (Human)) | BDBM236878 (US9388171, I-6) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.96 | n/a | n/a | n/a | n/a | n/a | 37 |
GENETECH, INC.; ARRAY BIOPHARMA INC. US Patent | Assay Description HepG2 cells were obtained from ATCC and grown in DMEM supplemented with 10% fetal bovine serum. Cells were plated in 96-well plates at 35,000 cells/w... | US Patent US9388171 (2016) BindingDB Entry DOI: 10.7270/Q2ZC81SV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mitogen-activated protein kinase 1 [8-360] (Homo sapiens (Human)) | BDBM236889 (US9388171, II-46) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.5 | n/a | n/a | n/a | n/a | 7.3 | n/a |
GENETECH, INC.; ARRAY BIOPHARMA INC. US Patent | Assay Description Compounds were tested in an enzymatic assay using human ERK-2 (Mitogen Activated Kinase 1), recombinantly expressed as an n-terminal 6-His fusion pro... | US Patent US9388171 (2016) BindingDB Entry DOI: 10.7270/Q2ZC81SV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ribosomal protein S6 kinase alpha-1 (Homo sapiens (Human)) | BDBM236884 (US9388171, II-2) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 8.5 | n/a | n/a | n/a | n/a | n/a | 37 |
GENETECH, INC.; ARRAY BIOPHARMA INC. US Patent | Assay Description HepG2 cells were obtained from ATCC and grown in DMEM supplemented with 10% fetal bovine serum. Cells were plated in 96-well plates at 35,000 cells/w... | US Patent US9388171 (2016) BindingDB Entry DOI: 10.7270/Q2ZC81SV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ribosomal protein S6 kinase alpha-1 (Homo sapiens (Human)) | BDBM236879 (US9388171, I-8) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 9.84 | n/a | n/a | n/a | n/a | n/a | 37 |
GENETECH, INC.; ARRAY BIOPHARMA INC. US Patent | Assay Description HepG2 cells were obtained from ATCC and grown in DMEM supplemented with 10% fetal bovine serum. Cells were plated in 96-well plates at 35,000 cells/w... | US Patent US9388171 (2016) BindingDB Entry DOI: 10.7270/Q2ZC81SV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ribosomal protein S6 kinase alpha-1 (Homo sapiens (Human)) | BDBM236886 (US9388171, II-15) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 9.97 | n/a | n/a | n/a | n/a | n/a | 37 |
GENETECH, INC.; ARRAY BIOPHARMA INC. US Patent | Assay Description HepG2 cells were obtained from ATCC and grown in DMEM supplemented with 10% fetal bovine serum. Cells were plated in 96-well plates at 35,000 cells/w... | US Patent US9388171 (2016) BindingDB Entry DOI: 10.7270/Q2ZC81SV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ribosomal protein S6 kinase alpha-1 (Homo sapiens (Human)) | BDBM236885 (US9388171, II-12) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 14.8 | n/a | n/a | n/a | n/a | n/a | 37 |
GENETECH, INC.; ARRAY BIOPHARMA INC. US Patent | Assay Description HepG2 cells were obtained from ATCC and grown in DMEM supplemented with 10% fetal bovine serum. Cells were plated in 96-well plates at 35,000 cells/w... | US Patent US9388171 (2016) BindingDB Entry DOI: 10.7270/Q2ZC81SV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ribosomal protein S6 kinase alpha-1 (Homo sapiens (Human)) | BDBM236889 (US9388171, II-46) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 15.7 | n/a | n/a | n/a | n/a | n/a | 37 |
GENETECH, INC.; ARRAY BIOPHARMA INC. US Patent | Assay Description HepG2 cells were obtained from ATCC and grown in DMEM supplemented with 10% fetal bovine serum. Cells were plated in 96-well plates at 35,000 cells/w... | US Patent US9388171 (2016) BindingDB Entry DOI: 10.7270/Q2ZC81SV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ribosomal protein S6 kinase alpha-1 (Homo sapiens (Human)) | BDBM236877 (US9388171, I-5) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 16.3 | n/a | n/a | n/a | n/a | n/a | 37 |
GENETECH, INC.; ARRAY BIOPHARMA INC. US Patent | Assay Description HepG2 cells were obtained from ATCC and grown in DMEM supplemented with 10% fetal bovine serum. Cells were plated in 96-well plates at 35,000 cells/w... | US Patent US9388171 (2016) BindingDB Entry DOI: 10.7270/Q2ZC81SV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ribosomal protein S6 kinase alpha-1 (Homo sapiens (Human)) | BDBM236881 (US9388171, I-21) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 18.7 | n/a | n/a | n/a | n/a | n/a | 37 |
GENETECH, INC.; ARRAY BIOPHARMA INC. US Patent | Assay Description HepG2 cells were obtained from ATCC and grown in DMEM supplemented with 10% fetal bovine serum. Cells were plated in 96-well plates at 35,000 cells/w... | US Patent US9388171 (2016) BindingDB Entry DOI: 10.7270/Q2ZC81SV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mitogen-activated protein kinase 1 [8-360] (Homo sapiens (Human)) | BDBM236887 (US9388171, II-23) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 20.2 | n/a | n/a | n/a | n/a | 7.3 | n/a |
GENETECH, INC.; ARRAY BIOPHARMA INC. US Patent | Assay Description Compounds were tested in an enzymatic assay using human ERK-2 (Mitogen Activated Kinase 1), recombinantly expressed as an n-terminal 6-His fusion pro... | US Patent US9388171 (2016) BindingDB Entry DOI: 10.7270/Q2ZC81SV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ribosomal protein S6 kinase alpha-1 (Homo sapiens (Human)) | BDBM236888 (US9388171, II-37) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 30.4 | n/a | n/a | n/a | n/a | n/a | 37 |
GENETECH, INC.; ARRAY BIOPHARMA INC. US Patent | Assay Description HepG2 cells were obtained from ATCC and grown in DMEM supplemented with 10% fetal bovine serum. Cells were plated in 96-well plates at 35,000 cells/w... | US Patent US9388171 (2016) BindingDB Entry DOI: 10.7270/Q2ZC81SV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ribosomal protein S6 kinase alpha-1 (Homo sapiens (Human)) | BDBM236882 (US9388171, I-24) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 37.8 | n/a | n/a | n/a | n/a | n/a | 37 |
GENETECH, INC.; ARRAY BIOPHARMA INC. US Patent | Assay Description HepG2 cells were obtained from ATCC and grown in DMEM supplemented with 10% fetal bovine serum. Cells were plated in 96-well plates at 35,000 cells/w... | US Patent US9388171 (2016) BindingDB Entry DOI: 10.7270/Q2ZC81SV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ribosomal protein S6 kinase alpha-1 (Homo sapiens (Human)) | BDBM236887 (US9388171, II-23) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 65.1 | n/a | n/a | n/a | n/a | n/a | 37 |
GENETECH, INC.; ARRAY BIOPHARMA INC. US Patent | Assay Description HepG2 cells were obtained from ATCC and grown in DMEM supplemented with 10% fetal bovine serum. Cells were plated in 96-well plates at 35,000 cells/w... | US Patent US9388171 (2016) BindingDB Entry DOI: 10.7270/Q2ZC81SV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ribosomal protein S6 kinase alpha-1 (Homo sapiens (Human)) | BDBM236880 (US9388171, I-11) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 98.9 | n/a | n/a | n/a | n/a | n/a | 37 |
GENETECH, INC.; ARRAY BIOPHARMA INC. US Patent | Assay Description HepG2 cells were obtained from ATCC and grown in DMEM supplemented with 10% fetal bovine serum. Cells were plated in 96-well plates at 35,000 cells/w... | US Patent US9388171 (2016) BindingDB Entry DOI: 10.7270/Q2ZC81SV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ribosomal protein S6 kinase alpha-1 (Homo sapiens (Human)) | BDBM236883 (US9388171, I-30) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 476 | n/a | n/a | n/a | n/a | n/a | 37 |
GENETECH, INC.; ARRAY BIOPHARMA INC. US Patent | Assay Description HepG2 cells were obtained from ATCC and grown in DMEM supplemented with 10% fetal bovine serum. Cells were plated in 96-well plates at 35,000 cells/w... | US Patent US9388171 (2016) BindingDB Entry DOI: 10.7270/Q2ZC81SV | |||||||||||
More data for this Ligand-Target Pair |